DMAA

Drugs Made In America Acquisition Corp

Apr 09 • 04:00PM ET

10.52

0.00 0.00 %

Financial • Shell Companies • USA • NASD

Index	-	P/E	62.40	EPS (ttm)	0.17	Insider Own	13.69%	Shs Outstand	33.52M	Perf Week	0.14%
Market Cap	352.43M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	28.93M	Perf Month	0.43%
Enterprise Value	352.43M	PEG	-	EPS next Q	-	Inst Own	69.15%	Short Float	0.09%	Perf Quarter	1.30%
Income	5.65M	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	0.25	Perf Half Y	2.12%
Sales	0.00M	P/B	1.53	EPS next Y	-	ROA	4.73%	Short Interest	0.02M	Perf YTD	1.36%
Book/sh	6.89	P/C	-	EPS next 5Y	-	ROE	4.90%	52W High	10.52 -0.05%	Perf Year	4.84%
Cash/sh	0.00	P/FCF	-	EPS past 3/5Y	- -	ROIC	2.45%	52W Low	10.02 4.94%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	0.06% 0.15%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	-	ATR (14)	0.02	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.06	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	58.71	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	0.06	EPS Q/Q	1404.00%	SMA20	0.21%	Beta	0.00	Target Price	-
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	0.53%	Rel Volume	0.00	Prev Close	10.52
Employees	-	LT Debt/Eq	0.00	Earnings	-	SMA200	1.90%	Avg Volume	97.65K	Price	10.52
IPO	Feb 25, 2025	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	25	Change	0.00%

Drugs Made In America Acquisition Corp. is a blank check company, which engages in the provision of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on May 23, 2024 and is headquartered in Fort Lauderdale, FL.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DMAA

Drugs Made In America Acquisition Corp

Upgrade your Finviz experience